CervoMed Inc. (CRVO) stock
CRVONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$1.50−0.17 (-10.18%)
Close on Nov 17, 2026Market cap $22.68MP/E –Yield –
CervoMed ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
For fiscal 2022 it was -$3.48M. The highest annual figure on record is -$3.48M in fiscal 2022.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | -$3.48M | – |
| FY2021 | Dec 31, 2021 | -$24.58M | – |
| FY2020 | Dec 31, 2020 | -$15.87M | – |
| FY2015 | Dec 31, 2015 | -$6.38M | – |
| FY2014 | Dec 31, 2014 | -$14.05M | – |
| FY2013 | Dec 31, 2013 | -$12.68M | – |
| FY2012 | Dec 31, 2012 | -$11.63M | – |
| FY2011 | Dec 31, 2011 | -$16.36M | – |
| FY2010 | Dec 31, 2010 | -$7.59M | – |
See a number that looks wrong?